Technical Specifications Compounds Included: GHK-Cu, BPC-157, TB-500 Total Peptide Content: 70 mg (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500) Format: Lyophilized peptide blend Purity: 9899% (COA included) Appearance: Blue-tinted and white lyophilized peptide mixture Category: Research peptide reagent Intended Use Approved for: Laboratory experimentation In-vitro biochemical assays Multi-pathway mechanistic studies Preclinical, non-human research modeling Advanced peptide interaction analysis Academic or institutional research Not approved for: Human or veterinary consumption Injection, ingestion, inhalation, or topical application Cosmetic, dermatological, or therapeutic purposes Any clinical or medical application This product is not approved by FDA, Health Canada, or similar regulatory bodies for human use
The most reliable benefits come from correcting deficiency or maintaining levels when your body cannot keep them up naturally
Now that we have forged links with the BSH we look forward to being involved in all manner of activities in the future
R.GravanisI.TsirkaS
CNN: Peptides, FDA compounding pharmacies, and the 2026 meeting National reporting on peptide demand, compounding, and the FDA meeting
If eligible, the physician sends your prescription to the pharmacy